Fujimoto J, Hori M, Ichigo S, Tamaya T
Department of Obstetrics and Gynecology, Gifu University School of Medicine, Japan.
Ann Clin Biochem. 1996 Nov;33 ( Pt 6):545-50. doi: 10.1177/000456329603300610.
In order to clarify a role of stromal cells in sex steroidal neovascularization, plasminogen activator inhibitor (PAI)-1 [an inhibitor of tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA)] and its messenger ribonucleic acid (mRNA) were analysed in fibroblasts derived from uterine endometrium as a model for endometrial stromal cells under the influence of sex steroids. The determinations were carried out by an enzyme-linked immunosorbent assay (ELISA) and reverse transcription-polymerase chain reaction-Southern blotting, respectively. In the fibroblasts, either estradiol or progestogens (progesterone, medroxy progesterone acetate or 17 alpha-hydroxyprogesterone) induced expressions of PAI-1 and its mRNA, and their combination further increased their expression by approximately twofold. PAI-1 from endometrial stromal cells under the influence of sex steroids might contribute to endometrial neovascularization through its effect on endothelial cells in endometrial vessels.
为了阐明基质细胞在性甾体诱导的血管生成中的作用,我们以受性甾体影响的子宫内膜基质细胞为模型,对源自子宫内膜的成纤维细胞中的纤溶酶原激活物抑制剂(PAI)-1 [组织型纤溶酶原激活物(tPA)和尿激酶型纤溶酶原激活物(uPA)的抑制剂] 及其信使核糖核酸(mRNA)进行了分析。分别通过酶联免疫吸附测定(ELISA)和逆转录-聚合酶链反应- Southern印迹法进行测定。在成纤维细胞中,雌二醇或孕激素(孕酮、醋酸甲羟孕酮或17α-羟孕酮)均可诱导PAI-1及其mRNA的表达,二者联合使用可使其表达进一步增加约两倍。受性甾体影响的子宫内膜基质细胞产生的PAI-1可能通过其对子宫内膜血管内皮细胞的作用,促进子宫内膜血管生成。